Oxford Asset Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-13,265
| Closed | -$141K | – | 914 |
|
2016
Q2 | $141K | Buy |
+13,265
| New | +$141K | ﹤0.01% | 718 |
|
2015
Q4 | – | Sell |
-1,570
| Closed | -$72K | – | 996 |
|
2015
Q3 | $72K | Buy |
+1,570
| New | +$72K | ﹤0.01% | 607 |
|
2015
Q1 | – | Sell |
-5,756
| Closed | -$216K | – | 798 |
|
2014
Q4 | $216K | Buy |
+5,756
| New | +$216K | ﹤0.01% | 622 |
|
2014
Q2 | – | Sell |
-2,901
| Closed | -$107K | – | 825 |
|
2014
Q1 | $107K | Sell |
2,901
-2,004
| -41% | -$73.9K | ﹤0.01% | 615 |
|
2013
Q4 | $203K | Buy |
+4,905
| New | +$203K | 0.01% | 644 |
|